DK1059092T3 - Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter - Google Patents

Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter

Info

Publication number
DK1059092T3
DK1059092T3 DK99111118T DK99111118T DK1059092T3 DK 1059092 T3 DK1059092 T3 DK 1059092T3 DK 99111118 T DK99111118 T DK 99111118T DK 99111118 T DK99111118 T DK 99111118T DK 1059092 T3 DK1059092 T3 DK 1059092T3
Authority
DK
Denmark
Prior art keywords
complexes
polydeoxyribonucleotides
cationic liposomes
drugs
polydeoxyribonucletoides
Prior art date
Application number
DK99111118T
Other languages
English (en)
Inventor
Laura Ferro
Elisabetta Esposito
Enea Menegatti
Roberto Porta
Fabio Trento
Claudio Nastruzzi
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Priority claimed from AU35010/99A external-priority patent/AU776014B2/en
Application granted granted Critical
Publication of DK1059092T3 publication Critical patent/DK1059092T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
DK99111118T 1999-06-08 1999-06-08 Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter DK1059092T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP99111118A EP1059092B1 (en) 1999-06-08 1999-06-08 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
CA002274419A CA2274419A1 (en) 1999-06-08 1999-06-11 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
AU35010/99A AU776014B2 (en) 1999-06-11 1999-06-11 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
US09/330,215 US6767554B2 (en) 1999-06-08 1999-06-11 Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments
KR1019990021947A KR100676492B1 (ko) 1999-06-08 1999-06-12 양이온성 리포솜 및 폴리데옥시리보누클레오티드 사이의 복합체의 약제로서의 용도
JP16700999A JP4598908B2 (ja) 1999-06-08 1999-06-14 カチオン性リポソームとポリデオキシリボヌクレオチドとの複合体

Publications (1)

Publication Number Publication Date
DK1059092T3 true DK1059092T3 (da) 2006-03-27

Family

ID=32330163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99111118T DK1059092T3 (da) 1999-06-08 1999-06-08 Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter

Country Status (9)

Country Link
US (1) US6767554B2 (da)
EP (1) EP1059092B1 (da)
JP (1) JP4598908B2 (da)
KR (1) KR100676492B1 (da)
AT (1) ATE311907T1 (da)
CA (1) CA2274419A1 (da)
DE (1) DE69928778T2 (da)
DK (1) DK1059092T3 (da)
ES (1) ES2251134T3 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4115833B2 (ja) 2000-10-12 2008-07-09 ユニバーシティー、オブ、メディシン、アンド、デンティストリー、オブ、ニュージャージー オリゴヌクレオチドが促進する合体
CA2491216C (en) * 2002-06-26 2012-01-03 Medigene Oncology Gmbh Method of producing a cationic liposomal preparation comprising a lipophilic compound
JP2006193461A (ja) * 2005-01-13 2006-07-27 Pola Chem Ind Inc 毛髪用の洗浄料
ITMI20051303A1 (it) * 2005-07-08 2007-01-09 Inxel S R L Metodo per la produzione di vernici in polvere termoindurenti particolarmente per l'applicazione mediante impianti elettrostatici
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
JPWO2008093848A1 (ja) * 2007-02-02 2010-05-20 サンスター株式会社 ホスファチジルコリンを含有する炎症マーカー低減組成物
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
US20100279353A1 (en) * 2009-04-30 2010-11-04 Shiu Nan Chen Process of producing fibrinolytic enzyme from mushroom
JP5142295B2 (ja) * 2009-05-08 2013-02-13 独立行政法人農業・食品産業技術総合研究機構 ベシクル及びその製法
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
ES2694239T3 (es) 2010-11-12 2018-12-19 Gentium S.R.L. Defibrótido para su uso en profilaxis y/o tratamiento de la enfermedad de Injerto contra huésped (GVHD)
GB201204632D0 (en) * 2012-03-16 2012-05-02 Univ Belfast Delivery system
KR102038357B1 (ko) 2012-06-22 2019-10-31 젠티엄 에스알엘 디파이브로타이드의 생물학적 활성 측정을 위한 유우글로불린에 기초한 방법
US11086970B2 (en) 2013-03-13 2021-08-10 Blue Belt Technologies, Inc. Systems and methods for using generic anatomy models in surgical planning
KR101534276B1 (ko) * 2014-07-18 2015-07-07 주식회사 에스씨301테라피 지방 이식 수술 후 지방세포 성장 및 생착 증진을 위한 조성물
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
TW201909904A (zh) 2017-08-03 2019-03-16 愛爾蘭商爵士製藥愛爾蘭有限責任公司 高濃度調配物
WO2019200251A1 (en) 2018-04-12 2019-10-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
KR102144615B1 (ko) * 2018-08-09 2020-08-13 장건주 폴리데옥시리보뉴클레오타이드를 포함하는 마이셀, 약물 전달체 및 이의 제조방법
KR102132478B1 (ko) * 2018-11-15 2020-07-10 (주)진우바이오 히알루론산-폴리데옥시리보뉴클레오타이드 복합체와 이를 활용한 필름 및 이의 제조방법
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
WO2021060440A1 (ja) 2019-09-26 2021-04-01 日油株式会社 脂質ナノ粒子の凍結乾燥組成物
WO2021174039A1 (en) 2020-02-28 2021-09-02 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome
CN115737470A (zh) * 2022-11-25 2023-03-07 润辉生物技术(威海)有限公司 一种肌肽-pdrn复合物及其制备方法和应用
CN115836982B (zh) * 2022-12-30 2024-02-06 南京乐韬生物科技有限公司 一种含pdrn的纳米乳液及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1043823B (it) 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
DE3017154A1 (de) 1980-05-05 1981-11-12 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3,-heptafluor-propan
HU192909B (en) * 1985-01-17 1987-07-28 Chinoin Gyogyszer Es Vegyeszet Process for producing interfuranylene-prostacycline derivatives
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
WO1990003795A1 (en) * 1988-10-05 1990-04-19 Vestar, Inc. Method of making liposomes with improved stability during drying
JPH04503957A (ja) * 1989-03-07 1992-07-16 ジェネンテク,インコーポレイテッド 脂質とオリゴヌクレオチドの共有結合コンジュゲート
EP0451791A2 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung
EP0539989B1 (de) 1991-11-01 1997-06-18 SOLVAY (Société Anonyme) Verfahren zur Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227)
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
DE59303465D1 (de) 1992-03-26 1996-09-26 Hoechst Ag Verfahren zur Reaktivierung eines bei der Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) eingesetzten Aktivkohle-Katalysators
US5395619A (en) * 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
DE4323054A1 (de) 1993-07-14 1995-01-19 Hoechst Ag Verfahren zur Herstellung von 2-H-Heptafluorpropan
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5908777A (en) * 1995-06-23 1999-06-01 University Of Pittsburgh Lipidic vector for nucleic acid delivery
DE69629702T2 (de) * 1995-08-01 2004-06-17 Isis Pharmaceuticals, Inc., Carlsbad Liposomale oligonukleotidzusammensetzungen
US5837283A (en) * 1997-03-12 1998-11-17 The Regents Of The University Of California Cationic lipid compositions targeting angiogenic endothelial cells

Also Published As

Publication number Publication date
JP4598908B2 (ja) 2010-12-15
KR20010002244A (ko) 2001-01-15
JP2001002565A (ja) 2001-01-09
US20020142029A1 (en) 2002-10-03
ES2251134T3 (es) 2006-04-16
CA2274419A1 (en) 2000-12-11
US6767554B2 (en) 2004-07-27
KR100676492B1 (ko) 2007-01-30
EP1059092A1 (en) 2000-12-13
DE69928778D1 (de) 2006-01-12
DE69928778T2 (de) 2006-07-06
ATE311907T1 (de) 2005-12-15
EP1059092B1 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
DK1059092T3 (da) Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter
DE3786000D1 (de) Conjugate dichter sterne.
NO20020033L (no) Zwitterioniske polymerer med höy molekylvekt
DE60033179D1 (de) Modifizierte polymere hergestellt mit katalysatoren auf basis von lanthaniden
CY1108279T1 (el) 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΑ ΚΑΙ ΕΝΔΙΑΜΕΣΑ ΠΡΟΪΟΝΤΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΑΥΤΩΝ, Η ΧΡΗΣΗ ΤΩΝ 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΩΝ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΜΕΣΩΝ ΚΑΘΩΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΑΡΑΣΚΕΥΑΣΜΑΤΑ
DE69912782D1 (de) Molekulargewichtserhöhung von polyestern
DE60016271D1 (de) Medikamentenzuführvorrichtung
ID26612A (id) Turunan-turunan siklobutena, pembuatannya dan penggunaan-penggunaan terapinya
ID23357A (id) Alas pembawa anak anak
FR2862975B1 (fr) Nouveaux agents epaississants a motifs cationiques et leur procede de preparation.
DE60009708T2 (de) Gewinnung von propan
ATE427938T1 (de) Herstellung von dibenzoab,fuazepine zwischenprodukte
DE69821984D1 (de) Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit
ATE430170T1 (de) Hochschlagfeste aromatische monovinylidenpolymere
ATE318834T1 (de) Lipide mit aminoxygruppe
ATE259385T1 (de) Polymerisationskatalysatoren
ZA9610511B (en) Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents.
AU2507601A (en) 11-beta-phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, production thereof and pharmaceutical compositions containing these compounds
IT1311974B1 (it) Polimeri dell'etilene.
ITRA970003U1 (it) Lettino da bambini con rotelle dondolabile.
ITMI960686A1 (it) Figurina adesiva con effetto tridimensionale o in rilievo,a ridotto costo di produzione,particolarmente per bambini.
SE9903295D0 (sv) Pump, företrädesvis som leksak
IT248917Y1 (it) Montante piatto per costruzioni componibili legate all'infanzia.
FI905644A0 (fi) Med pseudomonas aeruginosa reaktiva maenniskans monoklonala motkroppar, celler som kan producera dessa, foerfaranden foer framstaellning av dessa och farmaceutiska preparat innehaollande dessa.
IT1306840B1 (it) Procedimeto per la produzione di manufatti a base cementiziasuperficialmente colorati.